ALLOTEX
Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.
ALLOTEX
Industry:
Biotechnology Health Care Medical Device Therapeutics
Founded:
2014-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.allotex.com
Total Employee:
1+
Status:
Active
Contact:
617-391-9544
Total Funding:
30 M USD
Technology used in webpage:
Euro Cloudflare Hosting Pinterest FooBox
Similar Organizations
Carepoint Medical Solutions
Carepoint Medical Solutions offers pneumatic in-home compression therapies and equipment.
Hofesh
Hofesh offers technological solutions for treatment and rehabilitation purposes.
Neoptics
Neoptics provides a surgical solution for the refractive treatment of presbyopia.
NIDEK
Nidek offers a wide array of equipment designed for the diagnosis and treatment of retinal diseases, glaucoma, and other vision-impairing.
OYS Mobility
OYS Mobility develops prosthetic technology that allows people with limb loss or deformity to access healthcare and assistive devices.
Revascular Therapeutics
Revascular Therapeutics develops solutions for the treatment of total occlusions in arteries.
Spiration
Spiration is a developer of therapeutic medical devices for the treatment of air leaks and lung diseases.
Current Employees Featured
David Muller President, CEO & Founder @ Allotex
President, CEO & Founder
2013-01-01
Michael Mrochen Co-Founder @ Allotex
Co-Founder
2016-06-01
Founder
Investors List
Panakes Partners
Panakes Partners investment in Series B - Allotex
Supernova Invest
Supernova Invest investment in Series B - Allotex
Junson Capital
Junson Capital investment in Series B - Allotex
Exor Ventures
Exor Ventures investment in Series B - Allotex
KCK Medtech
KCK Medtech investment in Series B - Allotex
Official Site Inspections
http://www.allotex.com
- Host name: 104.21.64.1
- IP address: 104.21.64.1
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Allotex"
Allotex – Allograft Inlays & Onlays
Allotex Inc. is an ophthalmic biologics and device company developing new therapeutic solutions for the treatment of presbyopia, hyperopia, and myopia. The therapy is accomplished through …See details»
About - us.allotex.com
Today, Allotex’s advanced technologies have resolved both issues, and significant published clinical experience validates its solutions. 2. Allotex was founded in 2014 by Dr. David Muller, …See details»
Allotex - Crunchbase Company Profile & Funding
Organization. Allotex . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Allotex offers therapeutic solutions for the …See details»
Who We Are - us.allotex.com
The Allotex team consists of diverse, innovative, and talented leaders in the field. Leadership. David Muller, CEO. Prior to founding Allotex, Dr. Muller recognized the potential of a …See details»
Allotex Company Profile 2024: Valuation, Funding & Investors
Allotex General Information Description. Operator of an ophthalmic biologics and device company intended for the treatment of presbyopia, hyperopia and myopia. The company uses precisely …See details»
Allotex - LinkedIn
Allotex tissue addition symposium 2024: Episode 1/4 David Muller, CEO of Allotex, talks about the idea behind Allotex and its technology. Link to the full video here: https://lnkd.in/g_YNj25Q #AllotexSee details»
Allotex Company Profile: Overview and Full News Analysis
Allotex Inc., based in Massachusetts, is an innovative ophthalmic biologics and device company focused on developing advanced therapeutic solutions for presbyopia, hyperopia, and myopia. …See details»
Allotex - Products, Competitors, Financials, Employees, …
About Allotex. Allotex operates as an ophthalmic biologics and device company in the healthcare sector. The company develops therapeutic solutions for the treatment of various eye …See details»
Allotex - Funding, Financials, Valuation & Investors - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jul 9, 2023: Series B - Allotex . …See details»
Allotex - VentureRadar
Allotex Inc. is an ophthalmic biologics and device company developing new therapeutic solutions for improving the vision of millions of patient’s using allogeneic therapies. Allotex delivers …See details»
Allotex - Contacts, Employees, Board Members, Advisors & Alumni
Allotex offers therapeutic solutions for the treatment of presbyopia and hyperopia.See details»
Allotex | Ophthalmology Innovation Source
Allotex The driving force behind Allotex was the observation that the potential interest in synthetic corneal inlay technology was being dampened by the persistent biocompatibility issue. …See details»
Allotex Announces New Investor and Expansion of Production …
Nov 30, 2023 Allotex Inc. and SpA, a leading biologics and device company specializing in vision correction therapies, is pleased to announce that Junson Capital has joined its investor …See details»
Allotex Announces New Investor and Expansion of Production …
Nov 30, 2023 Allotex Inc. is a pioneering biologics and device company focused on developing innovative therapeutic solutions for vision correction. By utilizing precisely shaped human …See details»
Italian - American Allotex Secures 30m$ Funding for Allogeneic ...
Italian - American Allotex Secures 30m$ Funding for Allogeneic Presbyopia Inlays Boston, MA – Milan, Italy – July 9, 2023 – Allotex Inc. and SpA, a privately held clinical-stage medical …See details»
Allotex Receives Funding for Allogeneic Presbyopia Inlays | OBN
Jul 12, 2023 Allotex believes that this advancement has the potential to be a game-changer for the 135 million individuals with emmetropia in the United States and the European Union, …See details»
An Inside Look at Allotex - TMG Pulse
An Inside Look at Allotex Allotex Inc. is an ophthalmic biologics and device company developing new therapeutic solutions for the treatment of presbyopia, hyperopia, and myopia. The therapy …See details»
Conditions We Treat - us.allotex.com
The technology developed by Allotex’s medical engineers addresses two central areas of vision care: presbyopia and hyperopia. The typical treatment for these conditions can be …See details»
Allotex Announces Commencement of Final Phase of Presbyopia …
Apr 30, 2019 Allotex Inc. is an ophthalmic biologics and device company developing new therapeutic solutions for the treatment of presbyopia and hyperopia. ...See details»
Science - Allotex
The Allotex treatment is: Simple. Because Allotex Inlays use allograft tissue, our implants can be at the surface, making our treatment is the least invasive of all refractive procedures. Flexible. …See details»